MYH11
Myosin-11
Also known as: MYH11_HUMAN, SMHC, SMMHC, SMMS-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35749
- Gene
- MYH11
- Ensembl
- ENSG00000133392
- Chromosome
- 16
- Canonical length
- 1972 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a smooth muscle myosin belonging to the myosin heavy chain family. The gene product is a subunit of a hexameric protein that consists of two heavy chain subunits and two pairs of non-identical light chain subunits. It functions as a major contractile protein, converting chemical energy into mechanical energy through the hydrolysis of ATP. A chromosomal rearrangement involving this gene is associated with acute myeloid leukemia of the M4Eo subtype. Mutations in this gene are associated with visceral myopathy, megacystis-microcolon-intestinal hypoperistalsis syndrome 2, and familial thoracic aortic aneurysm 4. [provided by RefSeq, May 2022]
Canonical amino-acid sequenceUniProt
1972 residues, UniProt reviewed canonical sequence.
>P35749|MYH11
1 MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
61 ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
121 FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
181 GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
241 RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
301 LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
361 FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
421 VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
481 EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
541 FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
601 DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
661 LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
721 FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
781 ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
841 VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
901 ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
961 EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
1021 KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
1081 LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
1141 KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
1201 HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
1261 VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
1321 QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
1381 QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
1441 QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
1501 ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
1561 AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
1621 KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
1681 KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
1741 LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
1801 LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
1861 ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
1921 VNALKSKLRR GNETSFVPSR RSGGRRVIEN ADGSEEETDT RDADFNGTKA SELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYH11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 3,136 nTPM
Expression across tissuesHPA
Tissue
- colon: 3,136 nTPM
- blood vessel: 2,385 nTPM
- urinary bladder: 2,375 nTPM
- seminal vesicle: 1,569 nTPM
- smooth muscle: 981 nTPM
- endometrium: 972 nTPM
Single-cell type
- smooth muscle cells: 1,993 nCPM
- vascular smooth muscle cells: 1,313 nCPM
- peritubular myoid cells: 550 nCPM
- salivary myoepithelial cells: 307 nCPM
- breast myoepithelial cells: 295 nCPM
- pericytes: 114 nCPM
Immune cell
- neutrophil: 0.4 nTPM
- plasmacytoid DC: 0.2 nTPM
- basophil: 0.1 nTPM
- eosinophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- T-reg: 0.1 nTPM
Brain region
- basal ganglia: 31 nTPM
- cerebral cortex: 25 nTPM
- choroid plexus: 18 nTPM
- medulla oblongata: 14 nTPM
- thalamus: 9.5 nTPM
- midbrain: 9.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYH11.
Disease | AllUniProt
Conditions MYH11 is implicated in, by any mechanism.
- Aortic aneurysm, familial thoracic 4 (AAT4) MIM:132900
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 (MMIHS2) MIM:619351
- Visceral myopathy 2 (VSCM2) MIM:619350
Disease | GeneticClinVar
75 pathogenic / likely-pathogenic of 4,192 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Aortic aneurysm, familial thoracic 4
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 2
- Familial thoracic aortic aneurysm and aortic dissection
- Visceral myopathy 1
- Mitral regurgitation
Disease | ImmuneIEDB
Conditions an epitope on MYH11 was assayed in.
- hepatitis C B cell
- autoimmune hepatitis B cell
- sclerosing cholangitis B cell
- Alagille syndrome B cell
- Wilson disease B cell
- alpha 1-antitrypsin deficiency B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.77
- gnomAD missense Z
- 1.44
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actomyosin structure organization
- cardiac muscle cell development
- elastic fiber assembly
- skeletal muscle myosin thick filament assembly
- smooth muscle contraction
Molecular functions
- actin filament binding
- ATP binding
- calmodulin binding
- microfilament motor activity
- structural constituent of muscle
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYH11 as an antibody target. Whether an autoantibody or antibody against MYH11 could matter depends on whether native MYH11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYH11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYH11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...